InvestorsObserver
×
News Home

Is Amgen, Inc. (AMGN) a Bad Choice in Drug Manufacturers - General Tuesday?

Tuesday, December 07, 2021 01:08 PM | InvestorsObserver Analysts

Mentioned in this article

Is Amgen, Inc. (AMGN) a Bad Choice in Drug Manufacturers - General Tuesday?

Amgen, Inc. (AMGN) is near the middle in its industry group according to InvestorsObserver. AMGN gets an overall rating of 40. That means it scores higher than 40 percent of stocks. Amgen, Inc. gets a 53 rank in the Drug Manufacturers - General industry. Drug Manufacturers - General is number 89 out of 148 industries.

Overall Score - 40
AMGN has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on AMGN!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Amgen, Inc. Stock Today?

Amgen, Inc. (AMGN) stock is trading at $211.24 as of 1:00 PM on Tuesday, Dec 7, an increase of $2.45, or 1.17% from the previous closing price of $208.79. The stock has traded between $207.36 and $211.70 so far today. Volume today is less active than usual. So far 1,312,514 shares have traded compared to average volume of 2,941,494 shares. Click Here to get the full Stock Report for Amgen, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App